Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Drug for treatment of cerebrovascular disease

A cerebrovascular disease and drug technology, applied in the field of drugs for the treatment of cerebrovascular disease, can solve the problems of lack of treatment methods and difficulty in obtaining satisfactory curative effects, and achieve the effects of promoting rehabilitation, improving blood rheology and improving blood circulation.

Inactive Publication Date: 2016-05-11
宋淑芹
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In most ischemic cerebrovascular diseases, the inevitable death of nerve cells is the main cause of difficulty in achieving satisfactory curative effect
For the sequelae of cerebrovascular disease, there is currently no effective treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0008] The medicine of the present invention can be made into three dosage forms, namely Naosukang capsule, Naosukang acupoint sticker, and Naosukang drug test.

[0009] The preparation method of the Naosukang capsule of the present invention: weigh Salvia miltiorrhiza, Chuanxiong, pangolin, Polygonatum, Atractylodes, Angelica, Astragalus, Panax notoginseng, Cimicifuga, leech, Dilong, ox horn, whole scorpion and silkworm, and their weights are kilograms The numbers are 30, 12, 10, 15, 12, 15, 30, 6, 8, 3, 10, 15, 6, and 9. First, decoct and extract with water. Decoct for 1 hour, filter out the precipitate, combine the filtrates of the two times, and concentrate into a paste. At 70 degrees Celsius, the paste has a relative density of 1.28. The paste and alcohol with a purity of more than 95% are prepared into an ethanol solution with an alcohol content of 60-70. After stirring, let it stand for precipitation, and the supernatant is concentrated into a paste for later use. Add...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A drug for treatment of cerebrovascular disease is characterized by comprising 5-30 parts by weight of Salvia miltiorrhiza, 10-15 parts by weight of Ligusticum wallichii, 9-15 parts by weight of Manis pentadactyla, 10-15 parts by weight of rhizoma polygonati, 9-15 parts by weight of white atractylodes rhizome, 10-15 parts by weight of Chinese angelica, 15-30 parts by weight of Astragalus membranaceus, 3-9 parts by weight of pseudo-ginseng, 6-9 parts by weight of rhizoma cimicifugae, 2.5-5 parts by weight of leech, 6-10 parts by weight of earthworm, 10-15 parts by weight of ox horn, 3-6 parts by weight of scorpion and 4.5-10 parts by weight of stiff silkworm. The drug has the effects of activating blood circulation to dissipate stasis, clearing and activating the channels and collaterals, expanding blood vessels of brain, and improving blood circulation and blood rheology, and can be used for strokes caused by sputum stasis and collateral obstruction, symptoms are as follows: numbness of limbs, dizziness, speech disorder, skewed mouth and tongue, sluggish look, hemiplegia and sudden faint, also can treat ischemic cerebral embolism, cerebral vascular atherosclerosis and sequela of cerebral hemorrhage, can restore cerebral blood flows, promotes the rehabilitation of paralysis, and improves quality of living and life.

Description

technical field [0001] The present invention relates to a medicine for treating cerebrovascular disease through three administration routes. Background technique [0002] Cerebrovascular disease is a common and frequently-occurring disease in neurology. 50-70% of survivors are left with severe disabilities such as paralysis and aphasia, which brings a heavy burden to society and families. Cerebrovascular disease is divided into ischemic and hemorrhagic. It belongs to the categories of stroke, hemiplegia, and hemiplegia in Chinese medicine. At present, the drugs for the treatment of cerebrovascular diseases mainly include thrombolytics, anticoagulants, brain tissue protective agents and cerebral metabolism drugs; traditional Chinese medicine mostly uses decoctions or Chinese patent medicines (such as cerebral thrombus tablets) based on hemiplegia syndrome differentiation. Clinical application has strict treatment "time window" and contraindications, or the treatment scope i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8969A61P9/10A61K35/64A61K35/62A61K35/56A61K35/36A61K35/32
Inventor 宋淑芹
Owner 宋淑芹
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com